Cargando…
Ferroptosis in Glioma Immune Microenvironment: Opportunity and Challenge
Glioma is the most common intracranial malignant tumor in adults and the 5-year survival rate of glioma patients is extremely poor, even in patients who received Stupp treatment after diagnosis and this forces us to explore more efficient clinical strategies. At this time, immunotherapy shows great...
Autores principales: | Wang, Kaikai, Wang, Junjie, Zhang, Jiahao, Zhang, Anke, Liu, Yibo, Zhou, Jingyi, Wang, Xiaoyu, Zhang, Jianmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273259/ https://www.ncbi.nlm.nih.gov/pubmed/35832539 http://dx.doi.org/10.3389/fonc.2022.917634 |
Ejemplares similares
-
Opportunities and challenges related to ferroptosis in glioma and neuroblastoma
por: Chi, Huizhong, et al.
Publicado: (2023) -
Ferroptosis in glioma treatment: Current situation, prospects and drug applications
por: Zhou, Yuhang, et al.
Publicado: (2022) -
Microenvironment immune response induced by tumor ferroptosis—the application of nanomedicine
por: Yun, Tian, et al.
Publicado: (2022) -
Ferroptosis-Mediated Formation of Tumor-Promoting Immune Microenvironment
por: Bi, Qing, et al.
Publicado: (2022) -
Prognosis Analysis and Validation of m(6)A Signature and Tumor Immune Microenvironment in Glioma
por: Lin, Shaojian, et al.
Publicado: (2020)